Skip to main content
Clinical Trials/ACTRN12608000016336
ACTRN12608000016336CompletedPhase 2

Ascorbate supplementation in Kidney failure and effect on quality of life

The Canberra Hospital0 sites100 target enrollmentStarted: January 14, 2008Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Receiving maintenance dialysis treatment OR estimated Modification of Diet in Renal Diseases Glomerular Filtration Rate (MDRD GFR) of less than 20ml/min

Exclusion Criteria

  • Life expectancy less than 3 months
  • Primary hyperoxaluria
  • Clinically unstable
  • Unable to provide informed consent
  • Unwilling to cease non study ascorbate containing supplements
  • Not fluent in English

Investigators

Similar Trials